search
Back to results

3D Printed Bolus in Post-mastectomy Radiotherapy

Primary Purpose

Breast Neoplasms, Radiotherapy Side Effect

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images
Sponsored by
Jiangxi Provincial Cancer Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Neoplasms

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • breast cancer patients with post-mastectomy treatment

Exclusion Criteria:

  • NA

Sites / Locations

  • Jiangxi Cancer Hospital of Nanchang UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

3D-printed bolus

Conventional bolus

Arm Description

Outcomes

Primary Outcome Measures

dose comparison
The prescription dose was 50 Gy in 25 fractions. Dose-volume histograms (DVHs) were used dosimetric analysis. D98%, D50% and D2%, indicating dose to 98% (near-minimum dose), 50% and 2% (near-maximum dose) of both target volumes, and V95%, V100%, and V110% indicating percent volume receiving 95%, 100% and 110% of prescribed dose, were recorded

Secondary Outcome Measures

Full Information

First Posted
November 18, 2020
Last Updated
April 14, 2021
Sponsor
Jiangxi Provincial Cancer Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04685460
Brief Title
3D Printed Bolus in Post-mastectomy Radiotherapy
Official Title
Clinical Study of 3D Printed Bolus for Volumetric Modulated Arc Therapy of Post-mastectomy Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2020 (Actual)
Primary Completion Date
April 15, 2021 (Actual)
Study Completion Date
April 20, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Jiangxi Provincial Cancer Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Recently, there is growing interest in the application of three-dimensional (3D) printed bolus to radiotherapy.At present, the researches on the application of 3D-printed bolus in breast cancer are mainly focused on air gap between skin and bolus or electron beam conformal therapy [7,15], there are no clinical experience with customized 3D-printed bolus for volumetric modulated arc therapy (VMAT) in daily practice has been published up to now. We aim to evaluate dosimetry and application of 3D-printed bolus for the post-mastectomy radiotherapy (PMRT) with Volumetric modulated arc therapy (VMAT). Seventy five patients with breast cancer receiving radiotherapy following post-mastectomy in our department were randomly selected in this study. The accuracy of fit of the 3D-Printed bolus to the chest wall was improved significantly relative to conventional bolus.This study demonstrates customized 3D-printed bolus in post-mastectomy radiation therapy improves fit of the bolus compared to conventional bolus. Furthermore, VMAT based on 3D-printed bolus significantly improves the chest wall target coverage and the conformity of plan, and reduces the dose of ipsilateral lung and heart, compared to conventional bolus.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms, Radiotherapy Side Effect

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
3D-printed bolus
Arm Type
Experimental
Arm Title
Conventional bolus
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images
Intervention Description
customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images were used in this study.
Primary Outcome Measure Information:
Title
dose comparison
Description
The prescription dose was 50 Gy in 25 fractions. Dose-volume histograms (DVHs) were used dosimetric analysis. D98%, D50% and D2%, indicating dose to 98% (near-minimum dose), 50% and 2% (near-maximum dose) of both target volumes, and V95%, V100%, and V110% indicating percent volume receiving 95%, 100% and 110% of prescribed dose, were recorded
Time Frame
one year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: breast cancer patients with post-mastectomy treatment Exclusion Criteria: NA
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chunling Jiang, Phd,MD
Phone
+8613979109200
Ext
330029
Email
jclil2002@163.com
Facility Information:
Facility Name
Jiangxi Cancer Hospital of Nanchang University
City
Nanchang
State/Province
Jiangxi
ZIP/Postal Code
330029
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chunling Jiang, MD,PHD
Phone
+8613979109200
Email
jclil2002@163.com

12. IPD Sharing Statement

Learn more about this trial

3D Printed Bolus in Post-mastectomy Radiotherapy

We'll reach out to this number within 24 hrs